Uniunea Europeană -
română -
EMA (European Medicines Agency)
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, ereditar - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
takhzyro 150 mg
takeda pharmaceuticals international ag ireland branch - irlanda - lanadelumabum - sol inj. in seringa preumpluta - 150mg - alti agenti hematologici medicamente utilizate in angioedemul ereditar
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
takhzyro 300 mg
shire pharmaceuticals ireland limited - irlanda - lanadelumabum - sol. inj. in seringa preumpluta - 300mg - medicamente utilizate in angioedemul ereditar medicamente utilizate in angioedemul ereditar